Acute kidney injury
Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Acute kidney injury (AKI) is the medical condition that Revelation Biosciences's drug candidate Gemini aims to treat, representing a significant unmet medical need that the expanded advisory board will help address.
Jun 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Acute kidney injury live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard